Benign and malignant soft-tissue tumors: posttreatment MR imaging

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Soft-tissue sarcoma treatment involves aggressive multimodal therapy including radiation, chemotherapy, and surgery.
• Local recurrence is common after treatment, necessitating frequent follow-up imaging.
• Posttreatment imaging interpretation is challenging due to treatment-induced changes in the surgical bed.

Purpose of the Study:

• To outline a systematic approach for interpreting posttreatment magnetic resonance (MR) images in soft-tissue sarcoma patients.
• To differentiate between benign posttreatment changes and local tumor recurrence.
• To enhance the accuracy of recurrence detection in the monitoring of soft-tissue sarcoma patients.

Main Methods:

• Systematic review of posttreatment magnetic resonance (MR) imaging findings.
• Emphasis on integrating clinical and surgical history with pretreatment imaging.
• Analysis of common radiation and chemotherapy-induced changes.
• Evaluation of specific MR imaging sequences for differentiating hemorrhage and recurrence.

Main Results:

• Radiation therapy can cause soft-tissue trabeculation, increased fatty marrow, and focal marrow abnormalities.
• Chemotherapy may lead to increased tumor size due to hemorrhage.
• Myocutaneous flaps can mimic masses but show time-dependent MR changes.
• Recurrent tumors typically present as discrete nodules with signal characteristics similar to the original tumor.

Conclusions:

• A consistent imaging approach, combined with thorough patient history and pretreatment image review, is crucial.
• Understanding posttreatment changes improves the accuracy of monitoring and recurrence detection.
• Optimized MR imaging interpretation maximizes the detection of local recurrence in soft-tissue sarcoma.